CREATE-MOMNCT07795853
Creatine for Recovery and Thinking in Mothers
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved 2 months later.
See at-risk trials from University of North Carolina, Chapel Hill
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Notable Recruitment opened
- Primary and study completion pushed from May 10, 2027 to Jul 10, 2027
- Start date changed from estimate of Sep 8, 2026 to Sep 28, 2026
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Repeated Sprint Ability Peak Power
Timeframe: Change from baseline to 4 weeks post-supplementation.
Fatigue Index
Timeframe: Change from baseline to 4 weeks post-supplementation.
Secondary (4)
Skeletal Muscle Oxygen Recovery
Executive Function
Working Memory
Brain Creatine Concentration
Arms and interventions
Low-Dose Creatine MonohydrateExperimental
Participants consume 5 grams per day of creatine monohydrate for 28 consecutive days.
High-dose Creatine MonohydrateExperimental
Participants consume 10 grams per day of creatine monohydrate for 28 consecutive days.
Dietary supplements: Creatine Monohdyrate
Sites
1 site in 1 country
- Applied Physiology LaboratoryChapel Hill, North Carolina, United States